Gf Fund Management Co. Ltd. Immuneering Corp Transaction History
Gf Fund Management Co. Ltd.
- $5.85 Trillion
- Q4 2025
A detailed history of Gf Fund Management Co. Ltd. transactions in Immuneering Corp stock. As of the latest transaction made, Gf Fund Management Co. Ltd. holds 1,268 shares of IMRX stock, worth $8,115. This represents 0.0% of its overall portfolio holdings.
Number of Shares
1,268Holding current value
$8,115% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding IMRX
# of Institutions
73Shares Held
14.3MCall Options Held
0Put Options Held
0-
Vanguard Group Inc Valley Forge, PA2.42MShares$15.5 Million0.0% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD1.8MShares$11.5 Million0.0% of portfolio
-
Exodus Point Capital Management, LP New York, NY1.52MShares$9.71 Million0.11% of portfolio
-
Logos Global Management LP San Francisco, CA950KShares$6.08 Million0.72% of portfolio
-
Ken Griffin Citadel Advisors LLC | Chicago, Il943KShares$6.04 Million0.0% of portfolio
About Immuneering Corp
- Ticker IMRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 26,392,300
- Market Cap $169M
- Description
- Immuneering Corporation, a biopharmaceutical company, focuses on the oncology and neuroscience product candidates. Its lead product candidates include IMM-1-104, a dual-MEK inhibitor to treat patients with cancer, including pancreatic, melanoma, colorectal, and non-small cell lung cancer caused by mutations of RAS and/or RAF; and IMM-6-415 to tr...